Fischer Medical Ventures
Fischer Medical Ventures Share Price Chart
Fischer Medical Ventures last traded at ₹29.92 (2026-10-13). Over the past month the stock moved -14.8%, three months the stock moved -20.1%, year the stock moved -72.2%. Its closing range over 52 weeks is ₹29.90 – ₹117.65, with the latest close 74.6% below the high.
Closing prices up to 2026-10-13.
About Fischer Medical Ventures
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
Business Overview:[1] Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Fischer Medical Ventures reported sales of ₹81.92 crore (+249.5%) and net profit of ₹3.79 crore (-22.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 81.92 | 11.25 | 13.73 | 3.79 | 0.06 |
| Mar 2026 | 97.54 | -3.77 | -3.87 | -12.44 | -0.19 |
| Dec 2025 | 101.10 | 21.57 | 21.34 | 19.23 | 0.30 |
| Sep 2025 | 86.31 | 16.22 | 18.79 | 13.90 | 0.21 |
| Jun 2025 | 23.44 | 3.99 | 17.02 | 4.86 | 0.07 |
| Mar 2025 | 49.17 | 2.51 | 5.10 | 1.31 | 0.02 |
| Dec 2024 | 11.75 | 0.37 | 3.15 | -0.29 | -0.01 |
| Sep 2024 | 39.66 | 0.50 | 1.26 | 0.29 | 0.01 |
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|
| Sales growth | – | +136.5% | +131.6% | +117.6% | +760.4% | +98.4% | +249.5% |
| Operating profit growth | – | +0.0% | – | +3144.0% | +5729.7% | -250.2% | +182.0% |
| Net profit growth | – | -49.4% | – | +4693.1% | – | -1049.6% | -22.0% |
| EPS growth | – | -60.0% | – | +2000.0% | – | -1050.0% | -14.3% |
| OPM % | 3.2% | 5.1% | 17.0% | 18.8% | 21.3% | -3.9% | 13.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Fischer Medical Ventures reported sales of ₹309.00 crore (+178.4%) and net profit of ₹31.00 crore (+3000.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 309.00 | 43.00 | 14.00 | 31.00 | 0.47 |
| Mar 2025 | 111.00 | 3.00 | 3.00 | 1.00 | 0.23 |
| Mar 2024 | 21.00 | 2.00 | 9.00 | 2.00 | 0.34 |
| Mar 2023 | 0.00 | 0.00 | 11.00 | 0.00 | -2.33 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | – | +428.6% | +178.4% |
| Operating profit growth | – | +50.0% | +1333.3% |
| Net profit growth | – | -50.0% | +3000.0% |
| EPS growth | – | -32.4% | +104.3% |
| OPM % | 9.0% | 3.0% | 14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Fischer Medical Ventures.
Get Free AI Stock Analysis FREE →Latest News
-
Fischer Medical Ventures submits revised investor presentation for September call - scanx.trade
-
Fischer Medical Ventures appoints David Yeow as independent director - scanx.trade
-
Fischer Medical launches CLARION 64/128-slice AI CT system in India - scanx.trade
-
Fischer rises as its arm wins Catanduanes Integrated Digital Healthcare Project
-
Fischer Medical Ventures’ arm wins Catanduanes Integrated Digital Healthcare Project
-
FISCHER announces digital healthcare implementation project in Philippines - Business Standard
-
Fischer Medical Ventures shines as its arm enters into partnership with Parul Sevashram Hospital
-
Fischer Medical Ventures’ arm enters into partnership with Parul Sevashram Hospital
-
Fischer Medical subsidiary partners with Parul Sevashram Hospital for MRI suite - scanx.trade
-
Fischer Medical Ventures secures CDSCO import approval for Spincare system - scanx.trade
Frequently Asked Questions
What is Fischer Medical Ventures's current stock price?
Fischer Medical Ventures shares were last quoted at ₹29.92 (-1.5% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Fischer Medical Ventures?
Fischer Medical Ventures has a price-to-earnings (P/E) ratio of 79.58 and a price-to-book (P/B) ratio of 6.02. The industry P/E is 45.63.
What is the 52-week high and low of Fischer Medical Ventures?
The 52-week high of Fischer Medical Ventures is ₹121.45 and the 52-week low is ₹31.00.
What is the market cap of Fischer Medical Ventures?
The market capitalisation of Fischer Medical Ventures is about ₹2,370.37 crore.
How did Fischer Medical Ventures perform in its latest quarterly results?
In the latest quarter (Jun 2026), Fischer Medical Ventures reported sales of ₹81.92 crore (+249.5%) and net profit of ₹3.79 crore (-22.0%), compared with the same quarter last year.
Is Fischer Medical Ventures a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Fischer Medical Ventures has a 3-year ROE of 6.00%, 3-year profit growth of 820.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Fischer Medical Ventures?
Promoters hold about 63.09% of Fischer Medical Ventures.
Which sector does Fischer Medical Ventures belong to?
Fischer Medical Ventures belongs to the Commodity Chemicals sector.